Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Christelle Foucher"'
Autor:
Christelle Foucher, Jean-François Bisson, Martine Guy, Hao Nguyen Trong, Sophie Hidalgo, Julie Colin, Anh Tu Tran Nguyen, Thao Vu Thi Phuong
Publikováno v:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 22
Introduction: Atopic dermatitis (AD) is a chronic, inflammatory skin disorder with eczematous and pruritic lesions. Topical moisturisers and either topical corticosteroids or calcineurin inhibitors are usually recommended. Restoring the skin barrier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6a1dd1af9a235551e76876cbaf09c4a
https://doi.org/10.2174/1871523022666230529150043
https://doi.org/10.2174/1871523022666230529150043
Autor:
Alain Serrie, Martine Guy, Florian Rigaudier, Christine Juhel, François-André Allaert, Christelle Foucher, Patrick Sichère, Georges Mayeux
Publikováno v:
Douleurs : Évaluation - Diagnostic - Traitement. 22:175-186
Resume Cet essai clinique randomise, croise, a demontre la securite et l’efficacite d’un dispositif medical de neurostimulation electrique transcutanee rechargeable (TENS) chez des sujets souffrant de douleurs articulaires et musculosquelettiques
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1765812ded2c2b4a1d9ad976e96d0fc5
https://doi.org/10.1016/j.douler.2021.05.004
https://doi.org/10.1016/j.douler.2021.05.004
Autor:
Anna Lochocka, Mario Berli, Cesar Gonzalo Calvo Vargas, Christelle Foucher, Petr Reichert, Axel Schaeffer, Hans-Friedrich Koch, Patrick Aubonnet, Dmitry Belenky
Publikováno v:
Cardiovascular Therapeutics. 33:329-337
SummaryAims Guidelines propose additional therapy to statin to treat elevated triglycerides (TG) and low high-density lipoprotein cholesterol (HDLC) in dyslipidemic patients. We evaluated the effects of new fixed-dose combinations (FDC) of fenofibrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2629503c4ff98b4cecf4ae29e190fcd9
https://doi.org/10.1111/1755-5922.12148
https://doi.org/10.1111/1755-5922.12148
Autor:
Boris Waldman, Val Gebski, Christelle Foucher, David R. Sullivan, Luke Buizen, Alicia J. Jenkins, Anthony C Keech, Timothy M. E. Davis, Liping Li, Russell S. Scott, Michael D. Feher, Y. Antero Kesäniemi, Jean-Claude Ansquer, Jeff R. Flack, Michael C d'Emden, Neil McGill, James D. Best, John D. Hedley
Publikováno v:
The lancet. Diabetesendocrinology. 6(4)
Gout is a painful disorder and is common in type 2 diabetes. Fenofibrate lowers uric acid and reduces gout attacks in small, short-term studies. Whether fenofibrate produces sustained reductions in uric acid and gout attacks is unknown.In the Fenofib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45cfd312b8df7d0928f0bf4b8668be4b
https://pubmed.ncbi.nlm.nih.gov/29571506
https://pubmed.ncbi.nlm.nih.gov/29571506
Publikováno v:
Current Pharmaceutical Biotechnology. 12:396-405
Diabetic retinopathy (DR) is one of the leading risk factors and causes of blindness worldwide. Tight glucose and blood pressure control has been shown to significantly decrease the risk of development as well as the progression of retinopathy and re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7142759a13f849b64ef04f082747c28
https://doi.org/10.2174/138920111794480570
https://doi.org/10.2174/138920111794480570
Publikováno v:
PROTEOMICS - Clinical Applications. 5:159-166
Purpose: Urinary peptidome changes and discrimination for potential renal glomerular and tubular damage after 6 wk of fenofibrate treatment were evaluated in 26 healthy subjects. Experimental design: Peptide profiling was performed in urine samples b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaedc0586b64faf5c5f32a04ddeeed48
https://doi.org/10.1002/prca.201000076
https://doi.org/10.1002/prca.201000076
Autor:
Christelle Foucher, Stephanie Rattier, David M. Flavell, John J.P. Kastelein, Jean-Claude Ansquer, Philippa J. Talmud, Steve E. Humphries, Simon N. Pimstone, George Steiner, Amir F. Ayyobi, Jiri Frohlich
Publikováno v:
Pharmacogenetics, 14(12), 823-829. Lippincott Williams and Wilkins
Objective The association between polymorphisms in candidate genes related to lipoprotein metabolism and the reduction in plasma triglyceride (TG) in response to fenofibrate treatment was evaluated in subjects with type 2 diabetes treated with micron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cc0e253ca751a1a9b87324bb37dc713
https://doi.org/10.1097/00008571-200412000-00005
https://doi.org/10.1097/00008571-200412000-00005
Autor:
Juha Vakkilainen, Anders Hamsten, Marja-Riitta Taskinen, Jean-Claude Ansquer, George Steiner, Francois Aubin, Christelle Foucher, Stephanie Rattier
Publikováno v:
Circulation. 107:1733-1737
Background— The Diabetes Atherosclerosis Intervention Study showed that treatment with fenofibrate decreases progression of coronary atherosclerosis in subjects with type 2 diabetes. We determined whether on-treatment plasma lipid concentrations an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90c78ce2e41512e6c658eb65cf29ac7b
https://doi.org/10.1161/01.cir.0000057982.50167.6e
https://doi.org/10.1161/01.cir.0000057982.50167.6e
Autor:
Elisabeth Cavallero, Christophe Corda, Nicole Navarro, Jean-Claude Ansquer, Claude Martin, Bernard Jacotot, Farideh Assadolahi, Irène Juhan-Vague, Christiane Dachet, Christelle Foucher
Publikováno v:
Atherosclerosis. 166:151-161
This study evaluated the postprandial (PP) response to an oral fat load in 28 male patients with type 2 diabetes (mean HbA1c of 5.1%), all receiving metformin and performing physical exercise, compared with healthy subjects. The effects of micronized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c34233ca7062a6887c70d3a3ca97c589
https://doi.org/10.1016/s0021-9150(02)00321-0
https://doi.org/10.1016/s0021-9150(02)00321-0
Autor:
Christopher J. McEntyre, Michael Lever, Stephen T. Chambers, Sandy Slow, Christelle Foucher, Peter M. George
Publikováno v:
Journal of clinical lipidology. 8(4)
Cross-sectional data suggest that bezafibrate increases betaine excretion in dyslipidemic patients.We aimed to demonstrate that fenofibrate induces increased betaine excretion in normal subjects and explore whether other 1-carbon metabolites and osmo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16c6f596b5c043e7c7b3b9b382acb7b1
https://pubmed.ncbi.nlm.nih.gov/25110225
https://pubmed.ncbi.nlm.nih.gov/25110225